Other captive investment companies
LYNGEN BIOMED AS
Revenue 2025
NOK 0
Operating profit
NOK −18,000
Equity
NOK −280,000
Incorporated
2012
Share capital
NOK 30,000
Roles
Daglig lederOddmund Johannes Johansen
Regnskapsfører
Styrets lederJohan Markus Johansen
StyremedlemSylvi Stenersen Hovdenak
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| SYLVI STENERSEN HOVDENAK | 50.0% | 1500.000000 | 2025 |
| MAREN MARIE THODE IVERSEN | 16.7% | 500.000000 | 2025 |
| ELINE DJUPVIK LARSEN | 16.7% | 500.000000 | 2025 |
| JOHAN MARKUS JOHANSEN | 16.7% | 500.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| CHONDRO ENGINEERING AS | Active | 4.2% | 2975.000000 |
| LYFSTONE AS | Active | 0.5% | 77008.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.